Insider filing · INCY
Barry P Flannelly
EVP & General Manager US
profile →
Incyte Corporation
INCY · Healthcare · 38 filings in 24 months
ticker →
Barry P Flannelly sold $1.3M of Incyte (INCY)
Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.
Value, as filed
$1.3M
19,147 sh × $67.68
Executed
Mar 14 2025
the trade date, as filed
Disclosed
Mar 18 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BFBarry P Flannelly (EVP & General Manager US) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Incyte Corporation (INCY). The largest single filing was $1.3M of INCY (19,147 sh × $67.68, as filed), executed Mar 14 2025.
The name
INCYHealthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Barry P Flannelly in INCY
INCYSALE
Incyte Corporation
$743K10,903 sh × $68.15
Exec Jul 3 2025
Filed Jul 7 2025 · 5:30 PM ET INCYSALE Incyte Corporation $293K
3,680 sh across 2 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET